Department of Gastroenterology and Pancreatology, Beaujon Hospital (AP-HP) and University Paris Diderot, Clichy, France.
Department of Digestive Oncology and Genetic Counselling, Beaujon Hospital (AP-HP) and University Paris Diderot, Clichy, France.
United European Gastroenterol J. 2019 Apr;7(3):358-368. doi: 10.1177/2050640618824910. Epub 2019 Jan 12.
About 5% of pancreatic ductal adenocarcinomas are inherited due to a deleterious germline mutation detected in 20% or fewer families. Pancreatic screening in high-risk individuals is proposed to allow early surgical treatment of (pre)malignant lesions. The outcomes of pancreatic surgery in high-risk individuals have never been correctly explored.
To evaluate surgical appropriateness and search for associated factors in high-risk individuals.
A patient-level meta-analysis was performed including studies published since 1999. Individual classification distinguished the highest risk imaging abnormality into low-risk or high-risk abnormality, and the highest pathological degree of malignancy of lesions into no/low malignant potential or potentially/frankly malignant. Surgical appropriateness was considered when potentially/frankly malignant lesions were resected.
Thirteen out of 24 studies were selected, which reported 90 high-risk individuals operated on. Low-risk/high-risk abnormalities were preoperatively detected in 46.7%/53.3% of operated high-risk individuals, respectively. Surgical appropriateness was consistent in 38 (42.2%) high-risk individuals, including 20 pancreatic ductal adenocarcinomas (22.2%). Identification of high-risk abnormalities was strongly associated with surgical appropriateness at multivariate analysis ( = 0.001). We proposed a score and nomogram predictive of surgical appropriateness, including high-risk abnormalities, age and existence of deleterious germline mutation.
Overall, 42.2% of high-risk individuals underwent appropriate surgery. The proposed score might help selecting the best candidates among high-risk individuals for pancreatic resection.
约 5%的胰腺导管腺癌是遗传性的,这是由于在 20%或更少的家族中检测到有害的种系突变。建议对高危个体进行胰腺筛查,以便早期手术治疗(前)恶性病变。高危个体的胰腺手术结果从未得到正确的探索。
评估高危个体手术的适宜性并寻找相关因素。
进行了一项基于患者的荟萃分析,包括自 1999 年以来发表的研究。个体分类将最高风险的影像学异常分为低风险或高风险异常,将病变的最高病理恶性程度分为无/低恶性潜能或潜在/明显恶性。当潜在/明显恶性病变被切除时,考虑手术的适宜性。
选择了 24 项研究中的 13 项,这些研究报告了 90 名接受手术的高危个体。术前分别在 46.7%和 53.3%的接受手术的高危个体中检测到低风险/高风险异常。在 38 名(42.2%)高危个体中,手术的适宜性是一致的,其中包括 20 名胰腺导管腺癌(22.2%)。多变量分析显示,高危异常的识别与手术的适宜性密切相关(=0.001)。我们提出了一个预测手术适宜性的评分和列线图,包括高危异常、年龄和有害种系突变的存在。
总体而言,42.2%的高危个体接受了适当的手术。所提出的评分可能有助于在高危个体中选择最适合胰腺切除术的候选者。